HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne M Etgen Selected Research

Lordosis

12/2019Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol.
11/2016Estrogen receptor α and β are involved in the activation of lordosis behavior in estradiol-primed rats.
9/2013Lordosis facilitation by leptin in ovariectomized, estrogen-primed rats requires simultaneous or sequential activation of several protein kinase pathways.
2/2012The nitric oxide pathway participates in lordosis behavior induced by central administration of leptin.
2/2011Leptin facilitates lordosis behavior through GnRH-1 and progestin receptors in estrogen-primed rats.
7/2010A role for Src kinase in progestin facilitation of estrous behavior in estradiol-primed female rats.
3/2009Nitric oxide and ERK/MAPK mediation of estrous behavior induced by GnRH, PGE2 and db-cAMP in rats.
5/2008Estradiol modulation of phenylephrine-induced excitatory responses in ventromedial hypothalamic neurons of female rats.
2/2008GnRH mediates estrous behavior induced by ring A reduced progestins and vaginocervical stimulation.
1/2007Facilitation of estrous behavior by vaginal cervical stimulation in female rats involves alpha1-adrenergic receptor activation of the nitric oxide pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne M Etgen Research Topics

Disease

23Lordosis
12/2019 - 02/2002
13Ischemia
07/2013 - 03/2002
3Brain Ischemia (Cerebral Ischemia)
06/2013 - 07/2009
2Body Weight (Weight, Body)
06/2012 - 09/2007
2Cognitive Dysfunction
03/2010 - 03/2007
2Heart Arrest (Cardiac Arrest)
07/2009 - 03/2002
2Weight Gain
07/2005 - 07/2004
1Glioblastoma (Glioblastoma Multiforme)
10/2010
1Glioma (Gliomas)
10/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2009
1Stroke (Strokes)
07/2009
1Alzheimer Disease (Alzheimer's Disease)
09/2008
1Hyperthermia
06/2007
1Brain Injuries (Brain Injury)
12/2006
1Wounds and Injuries (Trauma)
12/2006
1Insulin Resistance
07/2006
1Memory Disorders (Memory Loss)
02/2006

Drug/Important Bio-Agent (IBA)

22Estradiol (Delestrogen)FDA LinkGeneric
12/2019 - 09/2003
19Estrogens (Estrogen)FDA Link
09/2013 - 02/2002
10Hormones (Hormone)IBA
06/2013 - 03/2002
6ProgesteroneFDA LinkGeneric
07/2010 - 02/2002
5Estrogen ReceptorsIBA
11/2016 - 03/2007
4Mitogen-Activated Protein KinasesIBA
09/2013 - 12/2003
4Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2012 - 01/2004
4Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
02/2012 - 01/2004
32- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
12/2019 - 09/2003
3KT 5823IBA
12/2019 - 01/2004
3LeptinIBA
09/2013 - 02/2011
3Proteins (Proteins, Gene)FDA Link
07/2013 - 07/2005
3Neuroprotective AgentsIBA
09/2012 - 01/2010
3estradiol 3-benzoate (estradiol benzoate)IBA
02/2012 - 02/2002
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
02/2011 - 02/2008
3Caspase 3 (Caspase-3)IBA
03/2010 - 03/2002
3Insulin-Like Growth Factor I (IGF-1)IBA
03/2007 - 09/2003
3Progestins (Progestagens)IBA
12/2006 - 01/2004
3EnkephalinsIBA
04/2006 - 02/2002
2Protein Kinases (Protein Kinase)IBA
12/2019 - 09/2013
2Estrogen Receptor alphaIBA
11/2016 - 07/2005
2src-Family KinasesIBA
09/2013 - 07/2010
2Phosphotransferases (Kinase)IBA
09/2013 - 12/2003
2Messenger RNA (mRNA)IBA
07/2013 - 03/2002
2Estradiol Congeners (Synthetic Estrogens)IBA
06/2013 - 08/2011
2salicylhydroxamic acid (SHAM)IBA
09/2012 - 12/2006
2Nitric Oxide Synthase (NO Synthase)IBA
02/2012 - 01/2004
2Soluble Guanylyl CyclaseIBA
02/2012 - 01/2004
2iturelix (Antide)IBA
02/2011 - 02/2008
2Progesterone Receptors (Progesterone Receptor)IBA
02/2011 - 04/2006
2CaspasesIBA
03/2010 - 03/2007
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2007 - 12/2003
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
12/2006 - 09/2003
2D-Penicillamine (2,5)- EnkephalinIBA
04/2006 - 10/2002
2delta Opioid Receptors (delta Opioid Receptor)IBA
04/2006 - 10/2002
28-bromocyclic GMPIBA
12/2004 - 03/2002
25-alpha-Dihydroprogesterone (5 alpha-Dihydroprogesterone)IBA
12/2004 - 01/2004
2Opioid Analgesics (Opioids)IBA
10/2002 - 02/2002
2mu Opioid Receptors (mu Opioid Receptor)IBA
10/2002 - 02/2002
1Protein Kinase InhibitorsIBA
12/2019
1adenosine-3',5'-cyclic phosphorothioateIBA
12/2019
1protein kinase modulatorIBA
12/2019
1NAD (NADH)IBA
11/2016
1Benzoates (Benzoate)IBA
11/2016
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
09/2013
1bisindolylmaleimideIBA
09/2013
1Janus Kinase 2IBA
09/2013
1Protein Kinase CIBA
09/2013
1SurvivinIBA
07/2013
1CoumestrolIBA
09/2012
1Guanylate Cyclase (Guanylyl Cyclase)IBA
02/2012
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
02/2012
1Mifepristone (RU 486)FDA Link
02/2011
1Peptides (Polypeptides)IBA
02/2011
1SteroidsIBA
10/2010
12-MethoxyestradiolIBA
10/2010
1Aromatase (CYP19)IBA
10/2010
1EnzymesIBA
10/2010
1Testosterone (Sustanon)FDA Link
10/2010
1Selective Estrogen Receptor Modulators (SERM)IBA
10/2010
1Glycogen Synthase Kinase 3 betaIBA
03/2010
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
03/2010
1Glycogen Synthase (Synthase I)IBA
03/2010
1Gonadal Steroid Hormones (Sex Hormones)IBA
07/2009
1Dinoprostone (PGE2)FDA Link
03/2009
1CholesterolIBA
09/2008
1Megestrol Acetate (Borea)FDA LinkGeneric
02/2008
1Progesterone CongenersIBA
02/2008
1Pharmaceutical PreparationsIBA
09/2007
1Insulin-Like PeptidesIBA
09/2007
1Transcription Factors (Transcription Factor)IBA
03/2007
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2007
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
12/2006
1Leptin ReceptorsIBA
07/2006
1WAY 200070IBA
07/2005
1Fulvestrant (Faslodex)FDA Link
07/2005
1Estrogen Receptor betaIBA
07/2005
1Connexin 43 (Connexin43)IBA
05/2005
1CorticosteroneIBA
07/2004
1Serotonin (5 Hydroxytryptamine)IBA
07/2004

Therapy/Procedure

4Intraventricular Infusions
02/2012 - 02/2002
1Ovariectomy (Oophorectomy)
01/2010
1Therapeutics
03/2007